- Title
- Safety profile and metabolic effects of 14 days of treatment with DIO-902: Results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus
- Creators
- S. L. Schwartz (Author)Marc S. Rendell (Author) - Creighton UniversityA. J. Ahmann (Author)A. Thomas (Author)C. J. Arauz-Pacheco (Author)B. R. Welles (Author)
- Publication Details
- Clinical Therapeutics, Vol.30(6), pp.1081-1088
- Number of pages
- 1081-1088
- Identifiers
- 991005932141702656
- Academic Unit
- School of Medicine; Endocrine
- Resource Type
- Journal article
Journal article
Safety profile and metabolic effects of 14 days of treatment with DIO-902: Results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus
Clinical Therapeutics, Vol.30(6), pp.1081-1088
06/2008
PMID: 18640464
Metrics
4 Record Views